Industry Overview of Male Infertility Market

Male infertility lowers the chance of the affected individual to impregnate a fertile woman. It can also occur, owing to abnormal sperm function, blockages, and low sperm production that prevents the delivery of sperm. Genetic defects, undescended testicles, lifestyle choices, diabetes, and infections, such as chlamydia, gonorrhea, mumps, HIV, etc., are some of the common factors that cause male infertility. It can be treated by using vasoepididymostomy, hormone therapy, assisted reproductive technology (ART) procedures, including in vitro fertilization (IVF) and varicocele surgery, etc. These procedures aid in enhancing the reproductive health of males, restoring testosterone levels, improving the quality of sperm to enable pregnancy, etc.

How Big Is the Male Infertility Market?

The global male infertility market size reached US$ 3.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach a value of US$ 5.2 Billion by 2028 exhibiting a CAGR of 5.49% during 2023-2028.

Global Male Infertility Market Trends and Drivers:

The growing number of delayed pregnancies and the changing lifestyles of individuals are primarily driving the male infertility market. Additionally, the increasing adoption of deoxyribonucleic acid (DNA) fragmentation techniques and computer-assisted semen analysis to measure semen volume and diagnose hypospermia is further bolstering the market growth. Besides this, the escalating demand for ART procedures, such as IVF, that usually involve the utilization of previously frozen sperms is positively influencing the global market. Moreover, the launch of favorable policies by government bodies across countries to improve reimbursement scenarios for infertility-related treatments and enhance the safety of patient data is acting as another significant growth-inducing factor. Apart from this, the easy availability of several infertility treatment drugs, procedures, and devices is also stimulating the market growth. Furthermore, the rising accessibility to improved healthcare facilities is anticipated to fuel the male infertility market over the forecasted period.

Key Market Segmentation:

The report provides detailed segmentation of the global male infertility market based on based on test type, treatment, distribution channel, end user and industry vertical.

Breakup by Test Type:

  • Sperm Agglutination
  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Computer Assisted Semen Analysis
  • Sperm Penetration Assay
  • Others

Breakup by Treatment:

  • Medication
  • Assisted Reproductive Technology and Varicocele Surgery

Breakup by Distribution Channel:

  • Hospitals Pharmacies
  • Pharmacies and Drug Stores
  • Online Pharmacies

Breakup by End User:

  • Hospitals and Clinics
  • Fertility Centers
  • Research Institutes
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report provides a comprehensive analysis of the industry key players listed below:

The Major Players in the market are Andrology Solutions, CinnaGen Co., Halotech DNA, SCSA Diagnostics Inc., Vitrolife, Zydus Lifesciences Limited, Intas Pharmaceuticals Ltd. and Endo International plc.